Skip to main content
# Title Department Research Member Research Year
241 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ayat allah Ali yousseif 2021
242 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2021
243 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021
244 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
245 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Department of Pathology Dr. Marwa Tammam Ameen Hammam 2021
246 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
247 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Radiology Marwa Ali Mohammed Abdel fattah 2021
248 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
249 Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
250 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021